Skip to main content
Olokizumab proves noninferior to adalimumab for RA in phase 3 trial
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Olokizumab proves noninferior to adalimumab for RA in phase 3 trial
User login
Username
Password
Reset your password
Concept
Lead
score
Rheumatoid Arthritis
1
0.91
Receptors
0
0.7
Arthritis
0
0.52
Disability
0
0.17
Europe
0
0.17
Giant Cell Arteritis
0
0.17
Interleukin
0
0.75
Quality of Life
0
0.17
Tumor
0
0.17
UK Site Content
0
0.17
Biologic Therapy
0
0.16
Vasculitis
0
0.16
Specialty
Lead
score
Rheumatology
1
1
Internal Medicine
0
0.94
Family Medicine/Primary Care
0
0.79
Orthopaedics
0
0.78
Edit Tags